Central Nervous System Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Central Nervous System Therapeutics Market Report 2026

Name: Central Nervous System Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Anesthetics, Anticonvulsants, Antiemetics, Central Nervous System (CNS) Stimulants, Pain Relievers, Other Drug Classes), By Disease (Neurovascular Diseases, Mental Health, Degenerative Disorders, Genetic Diseases, Substance Abuse Disorders, Autoimmune And Inflammatory Diseases, Central Nervous System (CNS) Trauma, Infectious Diseases, Central Nervous System (CNS) Cancer, Other Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Application (Hospital, Clinic, Homecare, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Central Nervous System Therapeutics Market Overview

• Central Nervous System Therapeutics market size has reached to $134.99 billion in 2025

• Expected to grow to $206.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Increase In Mental Health Disorders Is Fueling Market Growth Due To Increasing Exposure To Chronic Stress

• Market Trend: Advancements In Capsid Engineering For Targeted Central Nervous System (CNS) Gene Therapy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Central Nervous System Therapeutics Market?

Central nervous system therapeutics refers to drugs and treatments designed to manage and treat disorders affecting the brain and spinal cord. These include conditions such as depression, epilepsy, Parkinson’s disease, and multiple sclerosis. It aims to restore neurological function, alleviate symptoms, and improve patients' quality of life. They may include pharmaceuticals, biologics, and advanced neurotechnological interventions.

The main drug class of central nervous system therapeutics are anesthetics, anticonvulsants, antiemetics, central nervous system (CNS) stimulants, pain relievers, and others. Anesthetics are medicines that stop pain or make you unconscious during medical procedures. The multiple diseases include neurovascular diseases, mental health, degenerative disorders, genetic diseases, substance abuse disorders, autoimmune and inflammatory diseases, central nervous system (CNS) trauma, infectious diseases, central nervous system (CNS) cancer, and others. The various distribution channels, such as hospital pharmacies, retail pharmacies, and others and cater to various applications, such as hospital, clinic, homecare, and others

Central Nervous System Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Central Nervous System Therapeutics Market Size and Share 2026?

The central nervous system therapeutics market size has grown strongly in recent years. It will grow from $134.99 billion in 2025 to $147.29 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing burden of depression and epilepsy, growing aging population, limited treatment options for degenerative disorders, rising hospitalization rates for cns conditions, expansion of hospital and clinic infrastructure.

What Is The Central Nervous System Therapeutics Market Growth Forecast?

The central nervous system therapeutics market size is expected to see strong growth in the next few years. It will grow to $206.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to development of novel neuroprotective agents, growth in biologics and gene-based therapies, increasing investment in neuroscience research, rising adoption of personalized medicine, expanding access to cns treatments in emerging markets. Major trends in the forecast period include rising prevalence of neurological and mental health disorders, growing adoption of combination therapies for cns diseases, increasing focus on long-term disease management and symptom control, expansion of homecare-based cns treatment solutions, improved drug formulations with better blood-brain barrier penetration.

Book your 30 minutes free consultation with our research experts

Global Central Nervous System Therapeutics Market Segmentation

1) By Drug Class: Anesthetics, Anticonvulsants, Antiemetics, Central Nervous System (CNS) Stimulants, Pain Relievers, Other Drug Classes

2) By Disease: Neurovascular Diseases, Mental Health, Degenerative Disorders, Genetic Diseases, Substance Abuse Disorders, Autoimmune And Inflammatory Diseases, Central Nervous System (CNS) Trauma, Infectious Diseases, Central Nervous System (CNS) Cancer, Other Diseases

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

4) By Application: Hospital, Clinic, Homecare, Other Applications

Subsegments:

1) By Anesthetics: General Anesthetics, Local Anesthetics, Dissociative Anesthetics, Inhalation Anesthetics, Intravenous Anesthetics

2) By Anticonvulsants: Sodium Channel Blockers, GABA Enhancers, Calcium Channel Blockers, SV2A Modulators, Mixed Mechanism Agents

3) By Antiemetics: Serotonin 5-HT3 Antagonists, Dopamine Antagonists, Neurokinin-1 (NK1) Receptor Antagonists, Antihistamines, Cannabinoids

4) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidates, Modafinil and Armodafinil, Caffeine-Based Stimulants, Xanthine Derivatives

5) By Pain Relievers: Opioid Analgesics, Antidepressants for Neuropathic Pain, Anticonvulsants for Pain Relief

6) By Other Drug Classes: Antipsychotics, Antidepressants, Muscle Relaxants, Sedatives and Hypnotics, Neuroprotective Agents

What Is The Driver Of The Central Nervous System Therapeutics Market?

The increasing prevalence of mental health disorders is expected to propel the growth of the central nervous system therapeutics market going forward. Mental health disorders refer to a wide range of conditions that affect a person’s thinking, feeling, behavior, or mood, such as depression, anxiety disorders, schizophrenia, and bipolar disorder. The rising prevalence of mental health disorders is due to increasing exposure to chronic stress, which can disrupt emotional regulation, weaken coping mechanisms, and contribute to conditions such as anxiety, depression, and burnout. Central Nervous System (CNS) therapeutics help treat mental health disorders by targeting brain chemicals and neural pathways involved in mood, behavior, and cognition. For instance, in December 2025, according to the report published by Bristol City Council, a UK-based local government authority, in Bristol, 66,815 patients aged 18 and over were recorded on GP practice depression registers in 2022-23, marking a 6.0% rise from 2021-22. Therefore, the increasing prevalence of mental health disorders is driving the growth of the central nervous system therapeutics industry.

Key Players In The Global Central Nervous System Therapeutics Market

Major companies operating in the central nervous system therapeutics market are Biogen Inc., Otsuka Pharmaceutical Co Ltd., UCB S.A., Jazz Pharmaceuticals plc, Supernus Pharmaceuticals Inc., Biohaven Ltd., Acadia Pharmaceuticals Inc., Neumora Therapeutics Inc., Cerevel Therapeutics LLC, Axsome Therapeutics Inc., TauRx Therapeutics Ltd., Autobahn Therapeutics, BrainStorm Cell Therapeutics Inc., Progentos Therapeutics Inc., Tonix Pharmaceuticals Holding Corp., Neuroplast B.V., Assertio Holdings Inc.

Global Central Nervous System Therapeutics Market Trends and Insights

Major companies operating in the central nervous system therapeutics market are focusing on developing innovative solutions such as capsid engineering to enhance targeted gene delivery, therapeutic efficacy, and blood-brain barrier penetration for improved treatment of neurological disorders. Capsid engineering refers to the modification and optimization of the protein shell (capsid) of viral vectors, typically adeno-associated viruses (AAVs), used in gene therapy. For instance, in May 2025, Coave Therapeutics S.A., a France-based biotechnology company, launched coAAV CSF 01, a novel adeno associated virus (AAV) for central nervous system (CNS) delivery using their proprietary ALIGATER platform. It demonstrated significantly enhanced transduction efficiency and safety compared to AAV9. When delivered via intracisternal magna and intracerebroventricular routes, coAAV-CSF-01 achieved 100-fold higher transgene expression in the cortex and 10,000-fold higher expression in the hippocampus at the same dose. Remarkably, equivalent expression levels to AAV9 were attained at just one-fifth of the dose, highlighting its superior potency. Additionally, the vector showed substantially reduced off-target expression in peripheral organs such as the liver while maintaining a favorable safety profile, including preserved peripheral nerve integrity. These results underscore the vector’s potential to enhance CNS gene therapy outcomes with improved precision and lower systemic risk.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Central Nervous System Therapeutics Market?

In June 2025, Supernus Pharmaceuticals Inc., a US-based biopharmaceutical company, acquired Sage Therapeutics Inc. for an undisclosed amount. Through this acquisition, Supernus Pharmaceuticals Inc. aims to expand its neuroscience portfolio, strengthen its position in the central nervous system (CNS) market, and accelerate the development of innovative treatments for depression and other mood disorders. Sage Therapeutics Inc. is a US-based biopharmaceutical company that focuses on central nervous system therapeutics.

Regional Insights

North America was the largest region in the central nervous system therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Central Nervous System Therapeutics Market?

The central nervous system therapeutics market consists of sales of sodium channel blockers, amphetamines, and neuroprotective agents. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Central Nervous System Therapeutics Market Report 2026?

The central nervous system therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the central nervous system therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Central Nervous System Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$147.29 billion
Revenue Forecast In 2035	$206.68 billion
Growth Rate	CAGR of 9.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Disease, Distribution Channel, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Biogen Inc., Otsuka Pharmaceutical Co Ltd., UCB S.A., Jazz Pharmaceuticals plc, Supernus Pharmaceuticals Inc., Biohaven Ltd., Acadia Pharmaceuticals Inc., Neumora Therapeutics Inc., Cerevel Therapeutics LLC, Axsome Therapeutics Inc., TauRx Therapeutics L
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Central Nervous System Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Central Nervous System Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Central Nervous System Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Central Nervous System Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Prevalence Of Neurological And Mental Health Disorders

4.2.2 Growing Adoption Of Combination Therapies For Cns Diseases

4.2.3 Increasing Focus On Long-Term Disease Management And Symptom Control

4.2.4 Expansion Of Homecare-Based Cns Treatment Solutions

4.2.5 Improved Drug Formulations With Better Blood-Brain Barrier Penetration

5. Central Nervous System Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Homecare Settings

5.4 Specialty Neurology Centers

5.5 Rehabilitation And Long-Term Care Centers

6. Central Nervous System Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Central Nervous System Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Central Nervous System Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Central Nervous System Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Central Nervous System Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Central Nervous System Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Central Nervous System Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Central Nervous System Therapeutics Market Segmentation

9.1. Global Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anesthetics, Anticonvulsants, Antiemetics, Central Nervous System (CNS) Stimulants, Pain Relievers, Other Drug Classes

9.2. Global Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neurovascular Diseases, Mental Health, Degenerative Disorders, Genetic Diseases, Substance Abuse Disorders, Autoimmune And Inflammatory Diseases, Central Nervous System (CNS) Trauma, Infectious Diseases, Central Nervous System (CNS) Cancer, Other Diseases

9.3. Global Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

9.4. Global Central Nervous System Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Clinic, Homecare, Other Applications

9.5. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

General Anesthetics, Local Anesthetics, Dissociative Anesthetics, Inhalation Anesthetics, Intravenous Anesthetics

9.6. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sodium Channel Blockers, GABA Enhancers, Calcium Channel Blockers, SV2A Modulators, Mixed Mechanism Agents

9.7. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Antiemetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Serotonin 5-HT3 Antagonists, Dopamine Antagonists, Neurokinin-1 (NK1) Receptor Antagonists, Antihistamines, Cannabinoids

9.8. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Central Nervous System (CNS) Stimulants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Amphetamines, Methylphenidates, Modafinil and Armodafinil, Caffeine-Based Stimulants, Xanthine Derivatives

9.9. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Pain Relievers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Opioid Analgesics, Antidepressants for Neuropathic Pain, Anticonvulsants for Pain Relief

9.10. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antipsychotics, Antidepressants, Muscle Relaxants, Sedatives and Hypnotics, Neuroprotective Agents

10. Central Nervous System Therapeutics Market Regional And Country Analysis

10.1. Global Central Nervous System Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Central Nervous System Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Central Nervous System Therapeutics Market

11.1. Asia-Pacific Central Nervous System Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Central Nervous System Therapeutics Market

12.1. China Central Nervous System Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Central Nervous System Therapeutics Market

13.1. India Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Central Nervous System Therapeutics Market

14.1. Japan Central Nervous System Therapeutics Market Overview

14.2. Japan Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Central Nervous System Therapeutics Market

15.1. Australia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Central Nervous System Therapeutics Market

16.1. Indonesia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Central Nervous System Therapeutics Market

17.1. South Korea Central Nervous System Therapeutics Market Overview

17.2. South Korea Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Central Nervous System Therapeutics Market

18.1. Taiwan Central Nervous System Therapeutics Market Overview

18.2. Taiwan Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Central Nervous System Therapeutics Market

19.1. South East Asia Central Nervous System Therapeutics Market Overview

19.2. South East Asia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Central Nervous System Therapeutics Market

20.1. Western Europe Central Nervous System Therapeutics Market Overview

20.2. Western Europe Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Central Nervous System Therapeutics Market

21.1. UK Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Central Nervous System Therapeutics Market

22.1. Germany Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Central Nervous System Therapeutics Market

23.1. France Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Central Nervous System Therapeutics Market

24.1. Italy Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Central Nervous System Therapeutics Market

25.1. Spain Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Central Nervous System Therapeutics Market

26.1. Eastern Europe Central Nervous System Therapeutics Market Overview

26.2. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Central Nervous System Therapeutics Market

27.1. Russia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Central Nervous System Therapeutics Market

28.1. North America Central Nervous System Therapeutics Market Overview

28.2. North America Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Central Nervous System Therapeutics Market

29.1. USA Central Nervous System Therapeutics Market Overview

29.2. USA Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Central Nervous System Therapeutics Market

30.1. Canada Central Nervous System Therapeutics Market Overview

30.2. Canada Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Central Nervous System Therapeutics Market

31.1. South America Central Nervous System Therapeutics Market Overview

31.2. South America Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Central Nervous System Therapeutics Market

32.1. Brazil Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Central Nervous System Therapeutics Market

33.1. Middle East Central Nervous System Therapeutics Market Overview

33.2. Middle East Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Central Nervous System Therapeutics Market

34.1. Africa Central Nervous System Therapeutics Market Overview

34.2. Africa Central Nervous System Therapeutics Market, Segmentation By Drug Class, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Central Nervous System Therapeutics Market Regulatory and Investment Landscape

36. Central Nervous System Therapeutics Market Competitive Landscape And Company Profiles

36.1. Central Nervous System Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Central Nervous System Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Central Nervous System Therapeutics Market Company Profiles

36.3.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Otsuka Pharmaceutical Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. UCB S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Supernus Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Central Nervous System Therapeutics Market Other Major And Innovative Companies

Biohaven Ltd., Acadia Pharmaceuticals Inc., Neumora Therapeutics Inc., Cerevel Therapeutics LLC, Axsome Therapeutics Inc., TauRx Therapeutics Ltd., Autobahn Therapeutics, BrainStorm Cell Therapeutics Inc., Progentos Therapeutics Inc., Tonix Pharmaceuticals Holding Corp., Neuroplast B.V.

38. Global Central Nervous System Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Central Nervous System Therapeutics Market

40. Central Nervous System Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Central Nervous System Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Central Nervous System Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Central Nervous System Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Central Nervous System Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Central Nervous System Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Central Nervous System Therapeutics Market, Supply Chain Analysis

Table 4: Global Central Nervous System Therapeutics Market, Major Raw Material Providers

Table 5: Global Central Nervous System Therapeutics Market, Major Resource Providers

Table 6: Global Central Nervous System Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Central Nervous System Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Central Nervous System Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Central Nervous System Therapeutics Market, Major Trends

Table 10: Global Central Nervous System Therapeutics Market, Major End Users

Table 11: Global Central Nervous System Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Central Nervous System Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Central Nervous System Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Central Nervous System Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Central Nervous System Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Antiemetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Central Nervous System (CNS) Stimulants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Pain Relievers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Central Nervous System Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Central Nervous System Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Central Nervous System Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Central Nervous System Therapeutics Market - Company Scoring Matrix

Table 101: Biogen Inc. Financial Performance

Table 102: Otsuka Pharmaceutical Co Ltd. Financial Performance

Table 103: UCB S.A. Financial Performance

Table 104: Jazz Pharmaceuticals plc Financial Performance

Table 105: Supernus Pharmaceuticals Inc. Financial Performance

Table 106: Global Central Nervous System Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Central Nervous System Therapeutics Market, Competitive Dashboard

Table 108: Global Central Nervous System Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Central Nervous System Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 110: Global, Central Nervous System Therapeutics Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 111: Global, Central Nervous System Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Central Nervous System Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Central Nervous System Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Central Nervous System Therapeutics Market, Supply Chain Analysis

Figure 4: Global Central Nervous System Therapeutics Market, Major Raw Material Providers

Figure 5: Global Central Nervous System Therapeutics Market, Major Resource Providers

Figure 6: Global Central Nervous System Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Central Nervous System Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Central Nervous System Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Central Nervous System Therapeutics Market, Major Trends

Figure 10: Global Central Nervous System Therapeutics Market, Major End Users

Figure 11: Global Central Nervous System Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Central Nervous System Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Central Nervous System Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Central Nervous System Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Central Nervous System Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Antiemetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Central Nervous System (CNS) Stimulants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Pain Relievers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Central Nervous System Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Central Nervous System Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Central Nervous System Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Central Nervous System Therapeutics Market - Company Scoring Matrix

Figure 101: Biogen Inc. Financial Performance

Figure 102: Otsuka Pharmaceutical Co Ltd. Financial Performance

Figure 103: UCB S.A. Financial Performance

Figure 104: Jazz Pharmaceuticals plc Financial Performance

Figure 105: Supernus Pharmaceuticals Inc. Financial Performance

Figure 106: Global Central Nervous System Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Central Nervous System Therapeutics Market, Competitive Dashboard

Figure 108: Global Central Nervous System Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Central Nervous System Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 110: Global, Central Nervous System Therapeutics Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 111: Global, Central Nervous System Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Outsourced Customer Care Services Market Report 2026 - Global Outlook – By Type (CRM Technology Hosting, Fulfillment Or Logistics, Customer Interaction), By Application (Pharma And Healthcare, Food And Beverages, Chemica...

Outsourced Software Testing Services Market Report 2026 - Global Outlook – By Type (Microsoft Windows, Mac OS X, Linux), By Application (Unit Testing, Integration Testing, End-To-End Functionality Testing, Usability Test...

Insurance Claims Services Market Report 2026 - Global Outlook – By Type Of Insurance (Life Insurance Claims, Health Insurance Claims, Motor Insurance Claims, Property And Casualty Insurance Claims), By Insurance Provider...

Insurance Agencies Market Report 2026 - Global Outlook – By Insurance (Life Insurance, Property And Casualty Insurance, Health And Medical Insurance, Other Insurance), By Mode (Online, Offline), By End User (Corporate, I...

Hospital Outsourcing Market Report 2026 - Global Outlook – By Hospital Type (Private, Public), By Hospital Size (Small And Medium Hospitals, Large Hospitals), By Services (Healthcare IT, Clinical Services, Business Servi...

Insurance Market Report 2026 - Global Outlook – By Type (Life Insurance, Property And Casualty Insurance, Health And Medical Insurance), By Mode (Online, Offline), By End User (Corporate, Individual) – Market Size, Trend...

Insurance Aggregators Market Report 2026 - Global Outlook – By Insurance Type (Life Insurance, Automotive Insurance, Health Insurance, Other Insurance Types), By Enterprise Type (Lead Generators, Call-Center Agencies, Di...

Frequently Asked Questions

How big is the Central Nervous System Therapeutics Market?

The Central Nervous System Therapeutics market was valued at $134.99 billion in 2025, increased to $147.29 billion in 2026, and is projected to reach $206.68 billion by 2030.

What is the Central Nervous System Therapeutics market growth?

The global Central Nervous System Therapeutics market is expected to grow at a CAGR of 8.8% from 2026 to 2035 to reach $206.68 billion by 2035.

Who are the key players in Central Nervous System Therapeutics market?

Some Key Players in the Central Nervous System Therapeutics market Include, Biogen Inc., Otsuka Pharmaceutical Co Ltd., UCB S.A., Jazz Pharmaceuticals plc, Supernus Pharmaceuticals Inc., Biohaven Ltd., Acadia Pharmaceuticals Inc., Neumora Therapeutics Inc., Cerevel Therapeutics LLC, Axsome Therapeutics Inc., TauRx Therapeutics Ltd., Autobahn Therapeutics, BrainStorm Cell Therapeutics Inc., Progentos Therapeutics Inc., Tonix Pharmaceuticals Holding Corp., Neuroplast B.V., Assertio Holdings Inc. .

What is the anticipated growth trend for the Central Nervous System Therapeutics market?

Major trend in this market includes: Advancements In Capsid Engineering For Targeted Central Nervous System (CNS) Gene Therapy. For further insights on this market. request a sample here

Which region has the most growth potential in the Central Nervous System Therapeutics market?

North America was the largest region in the central nervous system therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the central nervous system therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.